Analysts have been eager to weigh in on the Healthcare sector with new ratings on MacroGenics (MGNX), Bristol-Myers Squibb (BMY) and Pelthos Therap......

Analysts fell to the sidelines weighing in on Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) with n......

Berenberg Bank analyst reiterated a Buy rating on Bloomsbury Publishing today and set a price target of p825.00. The word on The Street in general,......

Bristol Myers Squibb ($BMY), a large U.S. drug firm focused on cancer, blood, and immune disease drugs, is teaming up with Anthropic to bring its C......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on UnitedHealth (UNH) and Bristol-Myers Squibb (BMY) wi......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on UnitedHealth (UNH) and Bristol-Myers Squibb (BMY) wi......

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. The REACH study looks at how doctors in China use luspater......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dexcom (DXCM) and Bristol-Myers Squibb (BMY) with bu......

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. This Phase 1 study from Bristol-Myers Squibb tests two tab......

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb (BMY) has completed a Phase 1 study t......